Valuation: Lamdong Pharmaceutical

Market Cap 152B 5.78M 5.07M 4.67M 4.35M 8.21M 549M 8.37M 56.17M 21.76M 270M 21.7M 21.23M 939M P/E 2024
18.7x
P/E 2025 5.47x
Enterprise Value 188B 7.16M 6.28M 5.78M 5.39M 10.16M 680M 10.37M 69.56M 26.95M 334M 26.87M 26.29M 1.16B EV / Sales 2024
0.77x
EV / Sales 2025 0.76x
Free-Float
62.01%
Yield 2024 *
-
Yield 2025 -
04-23 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
01-27 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
23/10/25 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
18/07/25 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
26/04/25 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/01/25 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
28/10/24 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
19/07/24 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
16/07/24 Lamdong Pharmaceutical Joint Stock Company acquired 6.02% stake in Big Invest Group Joint Stock Company. CI
16/07/24 An undisclosed buyer acquired 5.27% stake in Big Invest Group Joint Stock Company from Lamdong Pharmaceutical Joint Stock Company. CI
17/04/24 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
10/04/24 Lamdong Pharmaceutical Joint Stock Company announced that it expects to receive VND 90.75 billion in funding CI
29/01/24 Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
1 day-1.22%
1 week-4.71%
Current month-1.22%
1 month-4.71%
6 months-27.03%
Current year-27.03%
1 week 8,100
Extreme 8100
8,500
1 month 7,900
Extreme 7900
9,800
Current year 7,000
Extreme 7000
11,100
1 year 7,000
Extreme 7000
14,900
3 years 7,000
Extreme 7000
25,000
5 years 4,200
Extreme 4200
55,000
10 years 4,200
Extreme 4200
55,000
Manager TitleAgeSince
Chief Executive Officer - 05/07/2021
Director of Finance/CFO - 24/09/2020
Comptroller/Controller/Auditor 48 -
Director TitleAgeSince
Chairman 75 28/07/2010
Chairman - 05/07/2021
Director/Board Member - 26/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.22%-4.71%-25.00%+1.25% 5.78M
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.63%-0.96%+26.12%+20.22% 324B
+1.67%+0.26%+35.69%+35.90% 285B
+0.61%+0.02%+28.03%+42.33% 283B
-0.63%+2.04%-27.04%-40.50% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.14%+2.19%+22.35%+47.93% 358.07B
Weighted average by Cap. +0.27%+4.16%+38.29%+77.32%

Financials

2024 2025
Net sales 218B 8.3M 7.29M 6.71M 6.25M 11.79M 789M 12.03M 80.71M 31.27M 387M 31.18M 30.5M 1.35B 244B 9.29M 8.16M 7.51M 7M 13.2M 883M 13.46M 90.32M 34.99M 434M 34.89M 34.13M 1.51B
Net income 6.92B 264K 231K 213K 198K 374K 25.06M 382K 2.56M 993K 12.3M 990K 968K 42.81M 28.56B 1.09M 955K 879K 819K 1.55M 103M 1.58M 10.57M 4.1M 50.77M 4.08M 4M 177M
Net Debt 37.87B 1.44M 1.27M 1.17M 1.09M 2.05M 137M 2.09M 14.02M 5.43M 67.32M 5.42M 5.3M 234M 36.14B 1.38M 1.21M 1.11M 1.04M 1.96M 131M 2M 13.38M 5.19M 64.26M 5.17M 5.06M 224M
Logo Lamdong Pharmaceutical
Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
Employees
261
Date Price Change Volume
01/07/26 ₫8,100.00 -1.22% 106,522
30/06/26 ₫8,200.00 -2.38% 42,401
29/06/26 ₫8,400.00 -1.18% 80,000
26/06/26 ₫8,500.00 +1.19% 15,301
25/06/26 ₫8,400.00 -1.18% 303,939